“The NIH decision to restrict access to key genomic and medical datasets hinders global cooperation at a time when coordinated action is needed”, said Anjee Davis (Fight Colorectal Cancer, Springfield ...

Can you kindly explain the differences between Alzheimer’ disease, dementia, cognitive impairment and memory loss?Raimi (by SMS) Dementia is a catch-all term and covers all types of brain problems.

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function.

When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

In a new study, light exercise was as good as higher-intensity workouts at preventing brain changes that can lead to dementia ...

People with dementia can get care at home from family or appointed caretakers. Learn how dementia home care helps patients ...

AI model reveals the structural secrets of misfolded proteins. A new artificial intelligence (AI) tool has provided critical ...

A new study indicates that the drug suvorexant could reduce proteins associated with Alzheimer's by improving sleep quality.